Nationalität
USA
Geburtsjahr
1977
Mikrobiologie an der Miami University in Oxford, Ohio, B.A.
Business Administration an der University of California, San Diego, Californien, MBA
2002-2008
Verschiedene Account / Produkt Manager Rollen bei Roche Diagnostics, USA
2008-2010
Commercial Operations Manager, Japan / APAC, Tokio
2010-2012
Director Applied Science / Director Molecular Diagnostics Taiwan, Taipei City
2012-2014
Country Manager / Director Roche Diagnostics Irland, Dublin
2014-2016
President / General Manager, Roche Pharmaceuticals Peru, Lima
2016-2018
President / General Manager Roche Pharmaceuticals Korea, Seoul
2018-2019
Vice President, Lifecycle Leader für Tecentriq Lungen-, Kopf- und Halskrebs, Genentech, USA
2019
Senior Vice-President, Head of Global Commercial Product Strategy, Gilead Sciences, Foster City, USA
2019-2022
President & CEO Roche Diagnostics Corporation North America, Indianapolis, USA
Seit Januar 2023
CEO Roche Diagnostics, F. Hoffmann-La Roche Ltd., Basel, Switzerland